Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 1 June 1984:
Vol. 224. no. 4652, pp. 994 - 996
DOI: 10.1126/science.6372095
Prev | Table of Contents | Next

Articles

Science, Vol 224, Issue 4652, 994-996
Copyright © 1984 by American Association for the Advancement of Science

articles

Reversal of adriamycin resistance by verapamil in human ovarian cancer

AM Rogan, TC Hamilton, RC Young, RW Klecker Jr, and RF Ozols

The effectiveness of adriamycin in the treatment of ovarian cancer and other human tumors has been limited by the development of drug resistance. Verapamil, a calcium channel blocking agent, completely reversed adriamycin resistance in human ovarian cancer cells with moderate (three- to sixfold) degrees of resistance and partially reversed resistance in highly (150-fold) resistant cells. The potentiating effect of verapamil was due to inhibition of adriamycin efflux in the resistant cells. These results have led to a clinical trial of adriamycin and verapamil in refractory ovarian cancer patients.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A role for ceramide in driving cancer cell resistance to doxorubicin.
Y.-Y. Liu, J. Y. Yu, D. Yin, G. A. Patwardhan, V. Gupta, Y. Hirabayashi, W. M. Holleran, A. E. Giuliano, S. M. Jazwinski, V. Gouaze-Andersson, et al. (2008)
FASEB J 22, 2541-2551
   Abstract »    Full Text »    PDF »
Concise Review: Clinical Relevance of Drug Drug and Herb Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein).
S. Marchetti, R. Mazzanti, J. H. Beijnen, and J. H. M. Schellens (2007)
Oncologist 12, 927-941
   Abstract »    Full Text »    PDF »
Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells.
Y.-Y. Liu, T. Y. Han, J. Y. Yu, A. Bitterman, A. Le, A. E. Giuliano, and M. C. Cabot (2004)
J. Lipid Res. 45, 933-940
   Abstract »    Full Text »    PDF »
Improvement of Oral Drug Treatment by Temporary Inhibition of Drug Transporters and/or Cytochrome P450 in the Gastrointestinal Tract and Liver: An Overview.
C.M.F. Kruijtzer, J.H. Beijnen, and J.H.M. Schellens (2002)
Oncologist 7, 516-530
   Abstract »    Full Text »    PDF »
Peptide Transport by the Multidrug Resistance Protein MRP1.
M. C. de Jong, J. W. Slootstra, G. L. Scheffer, A. B. Schroeijers, W. C. Puijk, R. Dinkelberg, M. Kool, H. J. Broxterman, R. H. Meloen, and R. J. Scheper (2001)
Cancer Res. 61, 2552-2557
   Abstract »    Full Text »
In Vitro and in Vivo Reversal of P-Glycoprotein-mediated Multidrug Resistance by a Novel Potent Modulator, XR9576.
P. Mistry, A. J. Stewart, W. Dangerfield, S. Okiji, C. Liddle, D. Bootle, J. A. Plumb, D. Templeton, and P. Charlton (2001)
Cancer Res. 61, 749-758
   Abstract »    Full Text »
Cisplatin and Adriamycin Resistance Are Associated with MutLalpha and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line.
J. T. Drummond, A. Anthoney, R. Brown, and P. Modrich (1996)
J. Biol. Chem. 271, 19645-19648
   Abstract »    Full Text »    PDF »
Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells.
Y. Lavie, H.-t. Cao, S. L. Bursten, A. E. Giuliano, and M. C. Cabot (1996)
J. Biol. Chem. 271, 19530-19536
   Abstract »    Full Text »    PDF »
Markedly Decreased Expression of Glutathione S-Transferase [IMAGE] Gene in Human Cancer Cell Lines Resistant to Buthionine Sulfoximine, an Inhibitor of Cellular Glutathione Synthesis.
A. Yokomizo, K. Kohno, M. Wada, M. Ono, C. S. Morrow, K. H. Cowan, and M. Kuwano (1995)
J. Biol. Chem. 270, 19451-19457
   Abstract »    Full Text »    PDF »
Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum.
C. Wilson, A. Serrano, A Wasley, M. Bogenschutz, A. Shankar, and D. Wirth (1989)
Science 244, 1184-1186
   Abstract »    PDF »
Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.
S. Martin, A. Oduola, and W. Milhous (1987)
Science 235, 899-901
   Abstract »    PDF »
Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.
D. Shen, A Fojo, J. Chin, I. Roninson, N Richert, I Pastan, and M. Gottesman (1986)
Science 232, 643-645
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)